Most Recent
ASIC flags penalty privilege fight with Nuix directors
As it readies its civil penalty suit against tech company Nuix for trial, ASIC has flagged a possible dispute about the extent of penalty privilege pleaded by a handful of former and current directors named in the case.
Telstra, TPG give up fight over $1.8B network sharing deal
Telstra and TPG will not challenge a decision by the Australian Competition Tribunal to uphold the ACCC's rejection of their proposed regional network sharing agreement.
ACCC’s rejection of $1.8B Telstra, TPG deal stands on appeal
Telstra and TPG have lost their challenge to the ACCC’s decision refusing authorisation for a $1.8 billion regional network sharing agreement, with the Australian Competition Tribunal finding the deal would increase Telstra's dominance in the mobile phone market. 
Optus fronts Competition Tribunal to warn about ‘troubling’ $1.8B Telstra, TPG deal
Telstra and TPG have asked the Competition Tribunal to undo the ACCC's rejection of their proposed regional network sharing agreement, but fellow telco Optus has warned the deal would kneecap its ability to compete.
Judge ‘confused’ by ACCC’s rejection of $1.8B Telstra, TPG mobile network deal
The ACCC's rejection of a regional network arrangement between Telstra and TPG was "confusing" and the telecos might be free to vary the transaction, says a judge who is overseeing a challenge to the competition regulator's decision.
Bristol-Myers Squibb to open up cancer treatment program to settle Merck Sharpe & Dohme lawsuit
Bristol-Myers Squibb has agreed to open up its subsidised treatment program for stage IV melanoma patients to individuals who have been treated with drugs made by its competitors to settle a misuse of market power lawsuit brought by rival Merck Sharpe & Dohme.
Port of Newcastle can charge Glencore higher access fees, High Court rules
The Port of Newcastle has largely won its High Court fight with mining giant Glencore over access fees and will now be able to set a higher price for use of the port's facilities.
Bristol-Myers Squibb denies claims in Merck Sharp & Dohme’s misuse of market power case
Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival's claims.
Bristol-Myers Squibb accused of misusing market power with cancer treatment program
Merck Sharp & Dohme has filed a lawsuit accusing rival drug company Bristol-Myers Squibb of misusing its market power by restricting access to a treatment program for stage IV melanoma patients.
Apple will take fight with Epic Games to the High Court
Apple plans to appeal the Full Federal Court's decision that Epic Games' misuse of market power lawsuit over it App Store terms should be heard in Australia because the case raises issues of "fundamental public interest".